Ophthalmology & Vision Research
Glaucoma
Glaucoma is one of the leading causes of irreversible blindness worldwide, affecting millions of people across all age groups. CenExel partners with sponsors to advance innovative glaucoma treatments through precision-driven clinical research focused on protecting vision and improving patient outcomes.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Advancing Glaucoma Clinical Research
CenExel delivers specialized expertise in glaucoma and ophthalmology research through experienced investigators, advanced diagnostic technologies, and patient-focused trial execution. Our clinical teams support every phase of development from early-stage therapies to large-scale multicenter studies.
Conditions Covered
Glaucoma Conditions We Research
Our ophthalmology research sites support a broad range of glaucoma-related indications and vision disorders.
- Primary Open-Angle Glaucoma
- Angle-Closure Glaucoma
- Ocular Hypertension
- Normal-Tension Glaucoma
- Pediatric Glaucoma
- Secondary Glaucoma
- Chronic Glaucoma
- Glaucoma with Cataracts
Our Approach
Why Sponsors Choose CenExel for Glaucoma
CenExel combines ophthalmology expertise, advanced diagnostic capabilities, and high-quality patient care to support successful glaucoma clinical trials.
01
Specialized Ophthalmology Teams
Experienced investigators and site staff dedicated to glaucoma and vision research studies.
02
Advanced Imaging Technology
State-of-the-art diagnostic tools including OCT imaging, retinal scanning, and visual field testing.
03
Diverse Patient Access
Access to broad patient populations across multiple active ophthalmology research sites.
04
High-Quality Trial Execution
From startup through closeout, our teams maintain operational excellence and data quality across every study phase.
Phase Coverage
Supported Trial Phases
CenExel supports glaucoma clinical trials from first-in-human and proof-of-concept studies through Phase IV post-market research.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our experienced ophthalmology research teams support biomarker analysis, imaging validation, and patient-centric glaucoma treatment studies across all development stages.
Glaucoma Task Force
CenExel supports glaucoma and ophthalmic research through specialized investigators, advanced imaging technologies, and experienced patient recruitment teams dedicated to improving vision care outcomes.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
